About this Journal Publication ethics Editorial Board Editorial Council Editorial Office For the Authors Contacts
English

News feeds

Journal in Databases

eLIBRARY.RU - ÍÀÓ×ÍÀß ÝËÅÊÒÐÎÍÍÀß ÁÈÁËÈÎÒÅÊÀ

Google Scholar

Google Scholar

Main arrow Archive of previous Issues arrow ¹5 2014 (39) arrow Analysis of price level for essential drugs in tambov region
Analysis of price level for essential drugs in tambov region Print
Wednesday, 26 November 2014

N.S. Strekalova, D.A. Kuznetsov
Ryazan State Medical University named after I.P. Pavlov, Ministry of Health of the Russian Federation, Ryazan

Abstract. The aim of the study was to review regulatory documents on pharmaceuticals’ pricing, to analyze results of price monitoring for essential drugs in the Tambov region both at the outpatient and inpatient segments of the pharmaceutical market.

To study the topic the following questions were considered:

  1. What normative documents regulate pricing of pharmaceuticals in the Russian Federation?
  2. How does the government control pricing and range of pharmaceuticals in the regions of the Russian Federation?
  3. What is dynamics of prices on essential drugs in Tambov region?
  4. How effective is the current legislation related to pricing of essential drugs?

The study used system-view approach, methods of statistical analysis and extrapolation.

Research objects included: pharmaceutical organizations of different legal structures in Tambov region, data of the Tambov region Healthcare Department, legal and regulatory instruments related to pricing of pharmaceuticals.

Results of the study included the following:

  • In 2010, in the Tambov region international and domestic pharmaceuticals of outpatient and inpatient segment of different prices cheapened;
  • In 2011, price of pharmaceuticals slightly increased because many pharmacies tried to gain maximum retail margin on essential drugs to increase retail sales;
  • In 2012, a slight growth of purchasing prices of inpatient pharmaceuticals as well as prices of outpatient essential drugs of the cheapest price segment (pharmaceuticals priced under 50 rubles) was reported;
  • In 2013, the Tambov region witnessed decrease in prices of international and domestic essential drugs of all price segments of both outpatient and inpatient purposes.

Keywords: legal regulation; monitoring of pharmaceuticals’ prices.

 

References:

  1. Vital and essential medicines: cardiovascular system. [Internet] [cited 2014 Apr 14]. Available from: http://www.remedium.ru/section/state (In Russian).
  2. Amendments to the List of vital and essential medicines (VEM) for 2011 approved by the Regulation of the Government of the Russian Federation of 2010 November 11 ¹1938-r", by VEM packages, which prices have been included in the State Register of maximum wholesale prices for the medicines included in the VEM List (by the state of 2011 December 15): Regulation of the Government of the Russian Federation of 2010 November 11. ¹1938-r (the edition of Regulation of the Government of the Russian Federation of 2011 November 03 ¹1933-r). [Internet] [cited 2014 Apr 14]. Available from: http://www.zakonprost.ru/content/base/175257 (In Russian).
  3. On the government regulation of prices for medicines included in the List of vital and essential medicines: Regulation of the Government of the Russian Federation of 2010 October 29 ¹ 865. [Internet] [cited 2014 Apr 15]. Available from: http://www.rosminzdrav.ru/documents/7459-postanovlenie-pravitelstva-rf-865-ot-29-oktyabrya-2010-g (In Russian).
  4. Improvement of government regulation of prices for vital and essential medicines: Regulation of the Government of the Russian Federation of 2009 August 08 ¹ 654. [Internet] [cited 2014 Apr 12]. Available from: http://www.rg.ru/2009/08/14/lekarstva-dok.html (In Russian).
  5. Organization and implementation of monitoring of assortment and prices for vital and essential medicines: the Order of the Ministry of Health and Social Development of the Russian Federation of 2009 May 27 ¹ 277n. [Internet] [cited 2014 Apr 14]. Available from: http://base.garant.ru/4188416/ (In Russian).
  6. On developing the List of vital and essential medicines for 2013: Regulation of the Government of the Russian Federation of 30.07.2012 ¹ 1378-r. [Internet] [cited 2014 Apr 14]. Available from: http://www.consultant.ru/document/cons_doc_LAW_133531/ (In Russian).
  7. On approval of the Regulations of the Federal Service on supervision in health care: Regulation of the Government of the Russian Federation of 2004 June 30. ¹ 323. [Internet] [cited 2014 Apr 14]. Available from: http://base.garant.ru/12135989/ (In Russian).
  8. On approval of the List of vital and essential medicines: Regulation of the Government of the Russian Federation of 2009 December 30 ¹ 2135-r. Regulation of the Government of the Russian Federation [Internet] [cited 2014 Apr 12]. Available from: http://base.garant.ru/12172129/ (In Russian).
  9. On approval of the List of vital and essential medicines for 2012: Regulation of the Government of the Russian Federation of 2011 December 07, ¹ 2199-r. [Internet] [cited 2014 Apr 15]. Available from: http://www.rosminzdrav.ru/documents/7008-rasporyazhenie-pravitelstva-rf-2199-r-ot-7-dekabrya-2011-g (In Russian).
  10. Strekalova N.S., Kuznetsov D.A. Monitoring of prices in pharmaceutical market in Tambov region compared to the Russian Federation. Universitetskaya nauka: vzglyad v budushcheå. 2013; (2): 141-144. (In Russian).
  11. Strekalova N.S., Kuznetsov D.A. Regional aspects of monitoring of medicine prices (in Tambov region). “Human and medicine” XVIII Russian national congress. Moscow, April 11-15, 2011. Theses of reports. Moscow. 2011. p. 636. (In Russian).
  12. Strekalova N.S., Kuznetsov D.A. Analysis of results of monitoring of VEM price accessibility at a regional level. «Human and medicine» XXI Russian national congress. Moscow, April 7-11, 2014. Theses of reports. Moscow. 2014. p. 434. (In Russian).
  13. Sura M.V., Omel'yanovskiy V.V. Evolution of the expertise system at development of the List of vital and essential medicines. Meditsinskie tekhnologii. Otsenka i vybor. 2011; (3): 30-33. (In Russian).
  14. Charchyan B.E., Uvarov V.V. Management of price policy of pharmaceutical companies in the Russian market. Rossiyskiy vneshneekonomicheskiy vestnik. 2011; (2): 50-58. (In Russian).

Views: 16090

Be first to comment this article

Write Comment
  • Please keep the topic of messages relevant to the subject of the article.
  • Personal verbal attacks will be deleted.
  • Please don't use comments to plug your web site. Such material will be removed.
  • Just ensure to *Refresh* your browser for a new security code to be displayed prior to clicking on the 'Send' button.
  • Keep in mind that the above process only applies if you simply entered the wrong security code.
Name:
E-mail
Comment:

Code:* Code

Last Updated ( Monday, 01 December 2014 )
< Prev   Next >
home contact search contact search